Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Original Article

Dynamic analysis of acute deterioration in chronic liver disease patients using modified quick sequential organ failure assessment

Do Seon Song, Hee Yeon Kim, Young Kul Jung, Tae Hyung Kim, Hyung Joon Yim, Eileen L Yoon, Ki Tae Suk, Jeong-ju Yoo, Sang Gyune Kim, Moon Young Kim, Young Chang, Soung Won Jeong, Jae Young Jang, Sung-Eun Kim, Jung-Hee Kim, Jung Gil Park, Won Kim, Jin Mo Yang, Dong Joon Kim, Korean Acute-on-Chronic Liver Failure (KACLiF) study group, Ashok Kumar Choudhury, Vinod Arora, Shiv Kumar Sarin, APASL ACLF Research Consortium (AARC) for APASL ACLF working party

Clin Mol Hepatol. 2024;30(3):388-405. Published online April 11, 2024

DOI: https://doi.org/10.3350/cmh.2023.0563

View: 2690 Download: 106 Web of Science: 2 Crossref: 2

Snapshot

Recent updates on pharmacologic therapy in non-alcoholic fatty liver disease

Young Chang, Soung Won Jeong, Jae Young Jang

Clin Mol Hepatol. 2024;30(1):129-133. Published online October 13, 2023

DOI: https://doi.org/10.3350/cmh.2023.0356

View: 3151 Download: 167 Crossref: 3

Original Article

Core indicators related to the elimination of hepatitis B and C virus infection in South Korea: A nationwide study

Chang Hun Lee, Gwang Hyeon Choi, Hwa Young Choi, Sojung Han, Eun Sun Jang, Young Eun Chon, Young Chang, Kyung-Ah Kim, Do Young Kim, Hyung Joon Yim, Hye-Lin Kim, Sook-Hyang Jeong, In Hee Kim

Clin Mol Hepatol. 2023;29(3):779-793. Published online May 15, 2023

DOI: https://doi.org/10.3350/cmh.2023.0110

View: 4091 Download: 183 Web of Science: 6 Crossref: 7

Review

Therapeutic mechanisms and beneficial effects of non-antidiabetic drugs in chronic liver diseases

Han Ah Lee, Young Chang, Pil Soo Sung, Eileen L. Yoon, Hye Won Lee, Jeong-Ju Yoo, Young-Sun Lee, Jihyun An, Do Seon Song, Young Youn Cho, Seung Up Kim, Yoon Jun Kim

Clin Mol Hepatol. 2022;28(3):425-472. Published online July 1, 2022

DOI: https://doi.org/10.3350/cmh.2022.0186

View: 8857 Download: 403 Web of Science: 13 Crossref: 14

Cost-effectiveness of chronic hepatitis C screening and treatment

Hye Won Lee, Hankil Lee, Beom Kyung Kim, Young Chang, Jae Young Jang, Do Young Kim

Clin Mol Hepatol. 2022;28(2):164-173. Published online December 27, 2021

DOI: https://doi.org/10.3350/cmh.2021.0193

View: 6146 Download: 217 Web of Science: 15 Crossref: 13

Original Article

The cut-off value of transient elastography to the value of hepatic venous pressure gradient in alcoholic cirrhosis

Se Ri Ryu, Jeong-Ju Yoo, Seong Hee Kang, Soung Won Jeong, Moon Young Kim, Young Kyu Cho, Young Chang, Sang Gyune Kim, Jae Young Jang, Young Seok Kim, Soon Koo Baik, Yong Jae Kim, Su Yeon Park, Baigal Baymbajav

Clin Mol Hepatol. 2021;27(1):197-206. Published online December 3, 2020

DOI: https://doi.org/10.3350/cmh.2020.0171

View: 7707 Download: 189 Web of Science: 11 Crossref: 11

Clinical application of ultrasonography-guided percutaneous liver biopsy and its safety over 18 years

Young Chang, Jun Il Kim, Bora Lee, Sang Gyune Kim, Min Jung Jung, Young Seok Kim, Soung Won Jeong, Jae Young Jang, Jeong-Ju Yoo

Clin Mol Hepatol. 2020;26(3):318-327. Published online May 25, 2020

DOI: https://doi.org/10.3350/cmh.2019.0019n

View: 6903 Download: 260 Web of Science: 20 Crossref: 19

1 |

Viewed By 5112	MAFLD: How is it different from NAFLD?
Viewed By 5074	Examining the therapeutic landscape of beta-blockers in portal hypertension
Viewed By 4515	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 4490	Global incidence and prevalence of nonalcoholic fatty liver disease
Viewed By 4377	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma

Cited By 248	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 198	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 145	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 138	MAFLD: How is it different from NAFLD?
Cited By 114	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach

Search